standardization-maintenance-3d-canine-hepatic-intestinal-organoid

Standardization and Maintenance of 3D Canine Hepatic and Intestinal Organoid Cultures for Use in Biomedical Research

Dogs develop complex multifactorial diseases analogous to humans, including inflammatory diseases, metabolic diseases, and cancer. Therefore, they ...

canine-intestinal-organoids-in-a-dual-chamber-permeable-support-system

Canine Intestinal Organoids in a Dual-Chamber Permeable Support System

The permeable support system is typically used in conjunction with traditional two-dimensional (2D) cell lines as an in vitro tool for evaluating the oral ...

Iowa State University

Vancomycin resistant enterococci (VRE) are of significant public health concern. The identification of VRE in livestock and food has increased. The objective of this study was to determine if the transferrable vancomycin resistance genes vanA and vanB were present in probiotics marketed for use in animals that claimed to contain Enterococcus spp.

Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes.

Hospitalized horses are at risk for colic due to several factors, all of which may reduce voluntary water intake (VWI) further contributing to the development of colic during hospitalization. Our objectives were to determine if using flavored water (sweet feed, peppermint, or apple-flavored electrolyte) increases VWI of hospitalized horses and to determine if horses consumed more flavored water versus plain water. We hypothesized that (1) in hospitalized horses the availability of flavored water results in more VWI than the availability of unflavored water and that (2) average intake of flavored water is larger for flavored versus unflavored within the experimental (flavored) group. Four groups of hospitalized horses (n = 10/group) were recruited. All horses were provided two buckets of water. Control horses were provided two buckets of plain water. The other three groups were provided one bucket of plain water and one bucket of flavored water (sweet feed, peppermint, or a commercial apple-flavored electrolyte). The total and the flavor-specific water consumed was recorded during a 72-hour period. There was weak evidence to suggest that the use of flavored water increases median total water intake of hospitalized horses by a factor of 1.76 [95% CI: 0.98 to 3.11] for sweet feed (P = .05) and 1.85 [95% CI: 1.03 to 3.33] for peppermint (P = .04). The results strongly supported that horses consumed more sweet feed-flavored water (27.0 mL/kg/day [95% CI: 14.6 to 39.3] more water) compared with plain water (P = .0001).

The Effect of Water Flavor on Voluntary Water Intake in Hospitalized Horses.

Fecal microbiota transplant (FMT), a technique used to restore normal intestinal microbial communities, has been successful in treating humans with Clostridioides difficile colitis. Subsequently, FMT is being used in veterinary patients with suspected intestinal dysbiosis. Unfortunately, little data are available regarding best practices for FMT in horses. The objective of this study was to evaluate the effects of storing manure prepared for equine FMT (MP-FMT) at -20°C for up to 4 weeks and passage through a simulated proximal gastrointestinal (GI) tract on the viability of MP-FMT. The results of this study indicate that storage at -20°C for greater than 1 week and exposure to conditions consistent with the proximal GI tract significantly decreased viability of the microbial population, with gram-negative enteric bacteria most significantly impacted. This preliminary evaluation indicates that further work is necessary to determine best practices to preserve the viability MP-FMT in horses.

In Vitro Evaluation of the Effect of Storage at -20°C and Proximal Gastrointestinal Conditions on Viability of Equine Fecal Microbiota Transplant.

Rates of detecting ≥1 potential enteric pathogens (PEP) or toxins (PEP-T) in feces, blood, or both of horses ≥6 months of age with enteric disease and impact of multiple detections on outcome of horses with colitis has not been reported.

Detection of pathogens in blood or feces of adult horses with enteric disease and association with outcome of colitis.

Probiotics, by definition, are live micro-organisms and should remain viable when they reach the intended site of action which is typically the cecum and/or colon. In humans, probiotics often need enteric protection to survive transit through the proximal gastrointestinal (GI) tract. Typically, equine probiotics do not advertise enteric protection and to the author's knowledge the viability of equine probiotics after exposure to the proximal GI tract has not been evaluated. The objective of this study was to evaluate the effect of an in vitro simulation of the equine proximal GI tract on probiotic viability. We hypothesized that the simulated proximal GI tract would adversely effect microbial viability and that the adverse effects would be partially ameliorated by increasing the gastric pH to 4. A total of 11 products were evaluated of which six had at least one micro-organism that was adversely effected by exposure to the proximal GI tract and four of which had at least one micro-organism that was adversely affected when the gastric pH was increased to 4.0. Results from this study indicate that some micro-organisms in equine probiotics do not appear to be adversely affected by exposure to the equine proximal GI tract.

Effect of an In Vitro Proximal Gastrointestinal Tract on Viability of Commercially Available Equine Probiotics.

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex, multifactorial disorders that lead to chronic and relapsing intestinal inflammation. The exact etiology remains unknown, however multiple factors including the environment, genetic, dietary, mucosal immunity, and altered microbiome structure and function play important roles in disease onset and progression. Supporting this notion that the gut microbiota plays a pivotal role in IBD pathogenesis, studies in gnotobiotic mice have shown that mouse models of intestinal inflammation require a microbial community to develop colitis. Additionally, antimicrobial therapy in some IBD patients will temporarily induce remission further demonstrating an association between gut microbes and intestinal inflammation. Finally, a dysfunctional intestinal epithelial barrier is also recognized as a key pathogenic factor in IBD. The intestinal epithelium serves as a barrier between the luminal environment and the mucosal immune system and guards against harmful molecules and microorganisms while being permeable to essential nutrients and solutes. Beneficial (i.e., mutualists) bacteria promote mucosal health by strengthening barrier integrity, increasing local defenses (mucin and IgA production) and inhibiting pro-inflammatory immune responses and apoptosis to promote mucosal homeostasis. In contrast, pathogenic bacteria and pathobionts suppress expression and localization of tight junction proteins, cause dysregulation of apoptosis/proliferation and increase pro-inflammatory signaling that directly damages the intestinal mucosa. This review article will focus on the role of intestinal epithelial cells (IECs) and the luminal environment acting as mediators of barrier function in IBD. We will also share some of our translational observations of interactions between IECs, immune cells, and environmental factors contributing to maintenance of mucosal homeostasis, as it relates to GI inflammation and IBD in different animal models.

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.

Probiotics are defined as live microorganisms that confer a health benefit to the host when administered in adequate amounts, therefore the presence of viable microorganisms is essential. Previous studies reported inconsistencies when comparing contents of probiotics marketed for use in animals with label claims. However, to the author's knowledge the variability of the same product between different lots has yet to be evaluated. The objective of this observational study was to evaluate the content and inter-lot variability of commercial equine probiotic products using culture dependent and independent techniques. Eleven probiotics marketed for use in horses were evaluated for microbial content using culture-dependent and independent techniques. The content was then compared to microorganisms listed and quantities on the label of the probiotic. Statistical analyses were performed using a Kruskal-Wallis test. None of the 11 probiotics met their label claim. Nine of the 11 did not have statistically significant inter-lot variability. Several products lacked microorganisms listed on the label based on both culture and polymerase chain reaction (PCR) analyses.

Microbial Variability of Commercial Equine Probiotics.

Understanding factors influencing assessment of pain in horses will facilitate communication between veterinarians and horse owners.

ArticleTotal : 2	Year
Publication title Cited by 32	2022
Publication title Cited by 18	2022

Article	Year
Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes. BMC research notes\| PubMed ID: 32498700	2020
The Effect of Water Flavor on Voluntary Water Intake in Hospitalized Horses. Journal of equine veterinary science\| PubMed ID: 33663710	2021
In Vitro Evaluation of the Effect of Storage at -20°C and Proximal Gastrointestinal Conditions on Viability of Equine Fecal Microbiota Transplant. Journal of equine veterinary science\| PubMed ID: 33663713	2021
Detection of pathogens in blood or feces of adult horses with enteric disease and association with outcome of colitis. Journal of veterinary internal medicine\| PubMed ID: 34382708	2021
Effect of an In Vitro Proximal Gastrointestinal Tract on Viability of Commercially Available Equine Probiotics. Journal of equine veterinary science\| PubMed ID: 34416988	2021
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Frontiers in medicine\| PubMed ID: 34513862	2021
Microbial Variability of Commercial Equine Probiotics. Journal of equine veterinary science\| PubMed ID: 34670695	2021
Pain severity scores for common equine disorders as provided by horse owners and equine veterinarians. Equine veterinary journal\| PubMed ID: 35034381	2022

Jamie Kopper

Biography

JoVE Journal Publications

Other Publications